Pyramidion Technology Group, Inc. (OTCPK:PYTG) Breaking News -
September 12, 2018

Pyramidion Technology Group, Inc. (OTC: “PYTG”) Strengthens Board of Advisors with the Appointment of Dr. David M. Feldbaum

Weston, Florida – 9/12/2018 -- Pyramidion Technology Group, Inc. (OTCPK:PYTG) today announces that Dr. David M. Feldbaum MD, Fellow, American College of Surgeons (FACS), has been appointed to the Board of Advisors for PYTG.

David M. Feldbaum MD, FACS is certified in vascular surgery by the American Board of Surgery. Dr. Feldbaum completed a surgical residency at Montefiore Medical Center/Albert Einstein College of Medicine in New York City, and a vascular surgery fellowship at the Carolinas Heart Institute in North Carolina. He is affiliated with the Memorial Healthcare System, and Westside Regional Medical Center. He is also a member of the voluntary faculty clinical instructor of surgery at the University of Miami School of Medicine.

Dr. Feldbaum’s presence on the Board of Advisors seeks to bolster its already credential-filled advisory capacity by offering instrumental input on the implementation of whole-care wellness plans, and specific case-relevant treatment plans, related to his area of expertise. Dr. Feldbaum has a unique interest in Medical Cannabis affairs and is a strong advocate of the use of Cannabidiol (CBD) products as part of a health and wellness program for many patients.

CBD research has provided evidentiary findings demonstrating its potentially beneficial symptomatic relief for vast range of ailments, including rheumatoid arthritis, diabetes, alcoholism, post-traumatic stress disorder, epilepsy, antibiotic-resistant infections, neurological disorders, and muscular dystrophy, to name a few.

“I am pleased to take on this new position with PYTG and the CBD containing product lines of LeafyWell. I feel that we can make a difference in how these products are designed, created, and implemented in order to maximize the positive health-related benefits for many of us.” states Dr. Feldbaum.

PYTG’s advisory board has been charged with providing guidance and insight on formula creation along with implementation plans for the company’s products containing CBD oil including delivery methods such as tinctures, creams, edible products, drinks, and others. Aligning with medical-goal related product development, Dr. Feldbaum’s expertise of the cardiovascular system and cardiovascular health should prove to be an instrumental and integral part of the company’s future advances in product lines creation and development.

“Dr. Feldbaum is a leader in his field and as one of the most-well respected cardiovascular surgeons, we are certain his knowledge of the human cardiovascular system and responses to CBD oil containing products will lead to our continued creation of the most well-informed product lines around.”, states Carlos Hurtado CEO of PYTG.

On the appointments, CEO Carlos Hurtado said, “Pyramidion has a mission to make cannabis available to any patient who can benefit from safe and reliable sources. The addition of these Reputed Physicians to our Medical Board will lead to even greater access for patients to the best CBD Products in the Market and built a solid Doctors-Patient Relationship and changing their life for better health.

About Pyramidion Technology Group, Inc
Pyramidion Technology Group, Inc. ("PYTG" or the "Company") is best described as a business incubator. The purpose of our business model is to leverage equity, to acquire, merge and or joint venture with early stage companies in emerging sectors, to facilitate growth and cash flow utilizing a diverse distribution method.

Our intention is to develop and acquire fast growing companies in up-trending industries and positioning technology for economic growth. This platform will combine natural relationships, marketing synergies and distribution methods that enable combined companies to provide a wide variety of unique and complete solutions, services and necessities to consumers. We believe our overall business model could effectively create a company of unlimited opportunities for our growing shareholder base.

For more information on PYTG, please visit the Company's website at https://www.pytgcorp.com.com/.

To be added to the Company investor email list, please email info@pytgcorp.com with PYTG in the subject line.

FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance

on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For a discussion of these risks and uncertainties, please see our filings with the OTC Markets Group Inc. Our public filings with the OTC Markets Group Inc are available from commercial document retrieval services and at the website maintained by the OTC Markets at https://www.otcmarkets.com/stock/PYTG/filings.
Contact:
Investor Contact: info@pytgcorp.com
Phone: +1-954-329-2205
SOURCE Pyramidion Technology Group, Inc
 

Pyramidion Technology Group, Inc. (OTC: PYTG) Appoints New Scientific Advisory Board Team to Support Company Strategy in the Medical CBD Industry

Weston, Florida –August 30, 2018 -- Pyramidion Technology Group, Inc. (OTCPK:PYTG) today announced the appointment of a New Advisory Medical Board to lead the new direction of the company in the Medical Alternative Medicine and Natural Nutraceutical Products. The new Medical Board will bring an immense, collective and unique set of experiences in the Medical CBD affairs, unmatched leadership and guidance to help drive Pyramidion towards its strategic mission.

Mark Sabbota

Dr. Mark Sabbota is board-certified in cardiology and internal medicine. He earned his medical degree from Chicago College of Osteopathic Medicine in 1995. Dr. Sabbota completed his residencies at Botsford General Hospital in 1998 and 2001 and his fellowship at University of Michigan Medical Center in 2001.

On the appointment, CEO Carlos Hurtado, said, "Pyramidion has a mission to make CBD available to any patient who can benefit from safe and reliable sources. The addition of these Reputed Physicians to our Medical Board will lead to even greater access for patients to the best CBD Products in the Market and built a solid Doctors-Patient Relationship and changing their life for better health.

About Pyramidion Technology Group, Inc.

Pyramidion Technology Group, Inc. ("PYTG" or the "Company") is best described as a business incubator. The purpose of our business model is to leverage equity, to acquire, merge and or joint venture with early stage companies in emerging sectors, to facilitate growth and cash flow utilizing a diverse distribution method.

Our intention is to develop and acquire fast growing companies in up-trending industries and positioning technology for economic growth. This platform will combine natural relationships, marketing synergies and distribution methods that enable combined companies to provide a wide variety of unique and complete solutions, services and necessities to consumers. We believe our overall business model could effectively create a company of unlimited opportunities for our growing shareholder base.

For more information on PYTG, please visit the Company's website at https://www.pytgcorp.com

To be added to the Company investor email list, please email info@pytgcorp.com with PYTG in the subject line.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance

on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For a discussion of these risks and uncertainties, please see our filings with the OTC Markets Group Inc. Our public filings with the OTC Markets Group Inc are available from commercial document retrieval services and at the website maintained by the OTC Markets at https://www.otcmarkets.com/stock/PYTG/filings.

Contact:
Investor
Contact: info@pytgcorp.com
Phone: +1-954-651-6816
SOURCE Pyramidion Technology Group, Inc
 

Pyramidion Technology Group, Inc. (OTC: 'PYTG') Enters Into a Letter of Intent to Acquire NxGen Brands, LLC

Deal is company's first in line of acquiring companies that will deliver alternative medicine to Patients with Critical Conditions using Cannabinoids (CBD) Infused Products.

Weston, Florida –August 28, 2018 -- Pyramidion Technology Group, Inc. (OTCPK:PYTG) today announced the execution of a binding letter of intent to acquire NxGen Brands, LLC its web-portal http://www.LeafyWell.com of Denver, Colorado, one of the area's most well-known and successful CBD Marketing Groups ("NxGen"). Pursuant to the letter of Intent, PYTG will be acquiring NxGen operations, brands, and marketplace.

NxGen Brands, LLC; proudly boasts the best strains, products, and services available throughout the state of Colorado, from plant to edibles, vapes and more. "NxGen is a leader in the Alternative Medicine and Natural Nutraceutical Products offering proprietary brands such as those available through http://www.LeafyWell.com.

Cannabis is considered to be the largest cash crop in the United States, enjoying a growth rate of 77% over the last few years and continued future estimated growth rate to 700% by 2020 The Cannabis industry, present and future, has been said to be potentially more lucrative than corn, cotton, and wheat. In fact, according to UN data, the cannabis industry is around an estimated $142 billion. To put that in perspective, the global coffee market - one of the most valuable commodities on the planet - is valued at around $80 billion per year.

The bottom line is that Cannabis is now a viable industry that's making investors an absolute fortune.

The letter of intent from PYTG to acquire NxGen operations is just a Binding Contract and the proposed acquisition is subject only to finalize the execution of a definitive purchase agreement. In addition, the proposed acquisition would be subject to regulatory approvals and is expected to close on or before September 30th, 2018.

About Pyramidion Technology Group, Inc

Pyramidion Technology Group, Inc. ("PYTG" or the "Company") is best described as a business incubator. The purpose of our business model is to leverage equity, to acquire, merge and/or joint venture with early stage companies in emerging sectors, to facilitate growth and cash flow utilizing a diverse distribution method.

Our intention is to develop and acquire fast growing companies in up-trending industries and positioning technology for economic growth. This platform will combine natural relationships, marketing synergies and distribution methods that enable combined companies to provide a wide variety of unique and complete solutions, services and necessities to consumers. We believe our overall business model could effectively create a company of unlimited opportunities for our growing shareholder base.

For more information on PYTG, please visit the Company's website at https://www.pytgcorp.com/.

To be added to the Company investor email list, please email info@pytgcorp.com with PYTG in the subject line.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For a discussion of these risks and uncertainties, please see our filings with the OTC Markets Group Inc. Our public filings with the OTC Markets Group Inc are available from commercial document retrieval services and at the website maintained by the OTC Markets at https://www.otcmarkets.com/stock/PYTG/filings.

Contact:
Investor Relations: info@pytgcorp.com
Phone: +1-954-651-6816
SOURCE Pyramidion Technology Group, Inc

-------------------------------------------------------------------
About Pyramidion Technology Group, Inc.:

PYRAMIDION TECHNOLOGY GROUP, INC.
OTC MARKETS-(PYTG)
Pyramidion Technology Group, Inc. ("PYTG" or the “Company”) is a developing business incubator. The purpose of the company is leveraging equity to acquire, merge and or joint venture with early stage companies to facilitate growth and cash flow utilizing a diverse distribution platform. Our intention is to develop and acquire fast growing companies in up-trending industries and positioning the technology for economies of scale. This platform will combine natural relationship marketing synergies and distribution methods that enable the combined companies to provide a wide variety of unique and complete solutions, services and necessities to consumers. We believe our overall business model can effectively create a conglomerate of unlimited opportunities to our growing base of shareholders.

WHY PYRAMIDION?
> We Invest STRONG AND Early
> Retail Clothing and software
> More Than 30 Years Experience
> Leaders in medical software
> Medical and Medicinal products
> We Focus On UNTAPPED SECTORS

COMPANY PROFILE

Pyramidion Technology Group, Inc. OTC Markets (PYTG) We are a Distribution Company in the development stage exploring business opportunities to assist companies with their products, good or services.​

We believe our overall business model should effectively create a complete business solution platform of unlimited opportunities. This platform combines natural relationship marketing synergies and enables the combined companies to provide a wide variety of unique and complete solutions at cost savings to the consumer.

OUR TEAM
With over 30-years of combined experience in the technology and cannabis sectors, our management team is highly effective at creating a winning combination of products and services in the cannabis industry.

Carlos Hurtado- President
Mr. Hurtado was appointed Director on April 29, 2016. His 20 years’ experience which includes exceptional leadership skills which stems from his take-charge professionalism with follow-through commitment to ensure project completion utilizing his excellent management skills. Mr. Hurtado has a proven ability to plan and oversee projects from concept to successful conclusion. His strong interpersonal skills, ability to work well with individuals on all levels and skillful team building and leadership are qualities that an entrepreneurial venture requires. He provides strategic and tactical leadership to deliver revenue gains and cost savings through organizational development and workforce optimization.

Mr. Hurtado’s career dates back since 1995, which includes various corporate management roles with Hillshire Brands (f/k/a Sara Lee – North America Retail) - Orlando, FL, Frito-Lay Inc. – Bronx, NYC and Hershey Chocolate USA – Woodbury, NY and has worked as various management roles at the retail level.

Mr. Hurtado received a Bachelor’s of Science Degree in Business Management Administration in 1995 from St. John's University where he was also elected to various on campus leadership organizations.

OUR PORTFOLIO
Pyramidion Technology Group, Inc. is a holding company with related but distinct products, services, markets and opportunities. We specialize in identifying industries in the software, medical and non-medical application space.

Cannabis
We’re creating converts on a daily basis thanks to the pain-fighting power found in CBD products.

Software
We're identifying several software properties that can enhance our current portflio of products and services.

Medical
We're looking for enhanced medical solutions that enhance our industry products and services.

Technology
We've identified several non-medical technology applications that will further improve our portfolio of companies.

SOURCE: https://www.pytgcorp.com/

Disclaimer